Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study …
MJ Davies, DA D'Alessio, J Fradkin, WN Kernan… - Diabetes …, 2018 - Am Diabetes Assoc
The American Diabetes Association and the European Association for the Study of Diabetes
convened a panel to update the prior position statements, published in 2012 and 2015, on …
convened a panel to update the prior position statements, published in 2012 and 2015, on …
Type 2 diabetes
Summary 415 million people live with diabetes worldwide, and an estimated 193 million
people have undiagnosed diabetes. Type 2 diabetes accounts for more than 90% of patients …
people have undiagnosed diabetes. Type 2 diabetes accounts for more than 90% of patients …
[HTML][HTML] Sedentary time in adults and the association with diabetes, cardiovascular disease and death: systematic review and meta-analysis
Methods Medline, Embase and the Cochrane Library databases were searched for terms
related to sedentary time and health outcomes. Cross-sectional and prospective studies …
related to sedentary time and health outcomes. Cross-sectional and prospective studies …
[HTML][HTML] Once-weekly semaglutide in adults with overweight or obesity
JPH Wilding, RL Batterham, S Calanna… - … England Journal of …, 2021 - Mass Medical Soc
Background Obesity is a global health challenge with few pharmacologic options. Whether
adults with obesity can achieve weight loss with once-weekly semaglutide at a dose of 2.4 …
adults with obesity can achieve weight loss with once-weekly semaglutide at a dose of 2.4 …
2019 update to: management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European …
The American Diabetes Association and the European Association for the Study of Diabetes
have briefly updated their 2018 recommendations on management of hyperglycemia, based …
have briefly updated their 2018 recommendations on management of hyperglycemia, based …
[HTML][HTML] Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes
Background Tirzepatide is a dual glucose-dependent insulinotropic polypeptide and
glucagon-like peptide-1 (GLP-1) receptor agonist that is under development for the …
glucagon-like peptide-1 (GLP-1) receptor agonist that is under development for the …
[HTML][HTML] Semaglutide in patients with heart failure with preserved ejection fraction and obesity
MN Kosiborod, SZ Abildstrøm, BA Borlaug… - … England Journal of …, 2023 - Mass Medical Soc
Background Heart failure with preserved ejection fraction is increasing in prevalence and is
associated with a high symptom burden and functional impairment, especially in persons …
associated with a high symptom burden and functional impairment, especially in persons …
[HTML][HTML] Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for …
MJ Davies, DA D'Alessio, J Fradkin, WN Kernan… - Diabetologia, 2018 - Springer
Abstract The American Diabetes Association and the European Association for the Study of
Diabetes convened a panel to update the prior position statements, published in 2012 and …
Diabetes convened a panel to update the prior position statements, published in 2012 and …
Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial
D Rubino, N Abrahamsson, M Davies, D Hesse… - Jama, 2021 - jamanetwork.com
Importance The effect of continuing vs withdrawing treatment with semaglutide, a glucagon-
like peptide 1 receptor agonist, on weight loss maintenance in people with overweight or …
like peptide 1 receptor agonist, on weight loss maintenance in people with overweight or …
Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis
Objective To investigate the independent effects of intake of fruit and vegetables on
incidence of type 2 diabetes. Design Systematic review and meta-analysis. Data sources …
incidence of type 2 diabetes. Design Systematic review and meta-analysis. Data sources …